Columbia researchers have identified two new breast cancer genes that also cause Lynch syndrome.
Columbia University scientists study tumor revertants as possible new approach to cancer therapy.
Based on new evidence, laparoscopic surgery should be offered to most women with early-stage endometrial cancer, says Columbia’s gynecologic cancer chief.
A public-private research effort aims to develop more accurate ways of tracking a patient’s response to cancer therapy.
The drug, developed by Columbia and MSK researchers, selectively kills cancer cells and has shown activity against multiple malignancies in pre-clinical studies.
Bristol-Myers Squibb Company today announced that Columbia University Medical Center and Peter MacCallum Cancer Centre have joined the International Immuno-Oncology Network.